Trial Search Results
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Procedures
THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can safely prevent desaturation events in children under anesthesia.
Stanford is currently accepting patients for this trial.
- Device: High-flow nasal cannula
- Pediatric patients less than or equal to 18 years old undergoing general anesthesia
for procedures or surgeries at Lucile Packard Children's Hospital.
- Pregnancy, absence of parent or legal guardian able to provide written consent for
study participation, anatomical or surgical contraindications (epistaxis, basilar
skull fractures or abnormalities, nasal surgery or obstruction, nasal fractures, nasal
vascular abnormalities), papillomatosis, tracheostomy, emergent surgery for which
application of HFNC might delay surgery or might result in increased aspiration risk.
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study